Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan
MATTESON, E. L, LOWE, V. J, PRENDERGAST, F. G, CROWSON, C. S, MODER, K. G, MORGENSTERN, D. E, MESSMANN, R. A, LOW, P. S
Published in Clinical and experimental rheumatology (01.03.2009)
Get full text
Published in Clinical and experimental rheumatology (01.03.2009)
Journal Article
A Phase I Study of Combination Therapy with Immunotoxins IgG-HD37-Deglycosylated Ricin A Chain (dgA) and IgG-RFB4-dgA (Combotox) in Patients with Refractory CD19(+), CD22(+) B Cell Lymphoma
Messmann, R A, Vitetta, E S, Headlee, D, Senderowicz, A M, Figg, W D, Schindler, J, Michiel, D F, Creekmore, S, Steinberg, S M, Kohler, D, Jaffe, E S, Stetler-Stevenson, M, Chen, H, Ghetie, V, Sausville, E A
Published in Clinical cancer research (01.04.2000)
Get full text
Published in Clinical cancer research (01.04.2000)
Journal Article
Use of 99mTc-EC20 (a folate-targeted imaging agent) to predict response to therapy with EC145 (folate-targeted therapy) in advanced ovarian cancer
Symanowski, J. T., Maurer, A. H., Naumann, R. W., Shah, N. P., Morgenstern, D., Messmann, R. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer
Naumann, R. W., Symanowski, J. T., Ghamande, S. A., Gabrail, N. Y., Gilbert, L., Teneriello, M. G., Sutton, G., Lovejoy, C., Messmann, R. A.
Published in Journal of clinical oncology (20.06.2010)
Published in Journal of clinical oncology (20.06.2010)
Get full text
Journal Article
A phase I study of EC0225 administered weeks 1 and 2 of a 4-week cycle
Sharma, S., Sausville, E. A., LoRusso, P., Vogelzang, N. J., Samlowski, W. E., Carter, J., Forman, K., Bever, S., Messmann, R. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A phase I study of the folate-targeted conjugate EC0489 in patients with refractory or advanced metastatic cancer
Harb, W. A., Conley, B. A., LoRusso, P., Sausville, E. A., Heath, E. I., Chandana, S. R., Hamm, M., Carter, J., Perez, W. J., Messmann, R. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer
Naumann, R. W., Coleman, R. L., Burger, R. A., Herzog, T. J., Morris, R., Sausville, E. A., Kutarska, E., Ghamande, S. A., Gabrail, N. Y., De Pasquale, S., Nowara, E., Gilbert, L., Caton, J. R., Gersh, R. H., Teneriello, M. G., Harb, W. A., Konstantinopoulos, P., Symanowski, J. T., Lovejoy, C., Messmann, R. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Flavopiridol-related Proinflammatory Syndrome Is Associated with Induction of Interleukin-6
MESSMANN, Richard A, ULLMANN, Claudio Dansky, SENDEROWICZ, Adrian M, LAHUSEN, Tyler, KALEHUA, Audrey, WASFY, Jason, MELILLO, Giovanni, DING, Ivan, HEADLEE, Donna, FIGG, William D, SAUSVILLE, Edward A
Published in Clinical cancer research (01.02.2003)
Get full text
Published in Clinical cancer research (01.02.2003)
Journal Article
Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasms
Zhai, Suoping, Sausville, Edward A, Senderowicz, Adrian M, Ando, Yuichi, Headlee, Donna, Messmann, Richard A, Arbuck, Susan, Murgo, Anthony J, Melillo, Giovanni, Fuse, Eiichi, Figg, William D
Published in Anti-cancer drugs (01.02.2003)
Published in Anti-cancer drugs (01.02.2003)
Get more information
Journal Article